human lung cell line Search Results


96
ATCC human lung cancer cell line
Human Lung Cancer Cell Line, supplied by ATCC, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/human lung cancer cell line/product/ATCC
Average 96 stars, based on 1 article reviews
human lung cancer cell line - by Bioz Stars, 2026-03
96/100 stars
  Buy from Supplier

95
Genecopoeia nci h1975 cells genecopoeia sl003 experimental models
Nci H1975 Cells Genecopoeia Sl003 Experimental Models, supplied by Genecopoeia, used in various techniques. Bioz Stars score: 95/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/nci h1975 cells genecopoeia sl003 experimental models/product/Genecopoeia
Average 95 stars, based on 1 article reviews
nci h1975 cells genecopoeia sl003 experimental models - by Bioz Stars, 2026-03
95/100 stars
  Buy from Supplier

93
ATCC h441 human lung adenocarcinoma cell line
SP-A binds to EGFR in A549 cells, <t>H441</t> cells, and CHOK1 cells stably expressing EGFR. A, whole-cell lysate of A549 cells was immunoprecipitated (IP) with anti-EGFR monoclonal antibody Ab-11 or control IgG (0. 8 μg) at 4 °C for 16 h. The samples and BSA (200 ng/lane) were subjected to SDS-PAGE and transferred onto PVDF membranes. The membranes were incubated with or without SP-A (1 μg/ml) for 16 h. The membranes not incubated with SP-A were subjected to Western blotting using an anti-human EGFR monoclonal antibody (WB: EGFR). The membranes incubated with SP-A were then treated with an anti-human SP-A polyclonal antibody (SP-A pAb) or monoclonal antibodies PE10 (SP-A mAb (PE10)) or PC6 (SP-A mAb (PC6)), which was followed by incubation with HRP-labeled anti-rabbit IgG or anti-mouse IgG (upper panel). As a negative control, the membranes in the absence of incubation with SP-A were also incubated with an anti-human SP-A polyclonal antibody (WB: SP-A pAb) or monoclonal antibodies PE10 (WB: SP-A mAb (PE10)) or PC6 (WB: SP-A mAb (PC6)), which was followed by incubation with HRP-labeled anti-rabbit IgG or anti-mouse IgG (lower panel). The data are representative of three independent experiments. B and C, experimental paradigm described in A was performed in H441 cells (B) and CHOK1 cells stably expressing EGFR (C) by using an anti-human SP-A polyclonal antibody, which was followed by incubation with HRP-labeled anti-rabbit IgG. The data are representative of three independent experiments.
H441 Human Lung Adenocarcinoma Cell Line, supplied by ATCC, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/h441 human lung adenocarcinoma cell line/product/ATCC
Average 93 stars, based on 1 article reviews
h441 human lung adenocarcinoma cell line - by Bioz Stars, 2026-03
93/100 stars
  Buy from Supplier

90
LGC Promochem mrc-5 human embryonal lung fibroblast cell line
SP-A binds to EGFR in A549 cells, <t>H441</t> cells, and CHOK1 cells stably expressing EGFR. A, whole-cell lysate of A549 cells was immunoprecipitated (IP) with anti-EGFR monoclonal antibody Ab-11 or control IgG (0. 8 μg) at 4 °C for 16 h. The samples and BSA (200 ng/lane) were subjected to SDS-PAGE and transferred onto PVDF membranes. The membranes were incubated with or without SP-A (1 μg/ml) for 16 h. The membranes not incubated with SP-A were subjected to Western blotting using an anti-human EGFR monoclonal antibody (WB: EGFR). The membranes incubated with SP-A were then treated with an anti-human SP-A polyclonal antibody (SP-A pAb) or monoclonal antibodies PE10 (SP-A mAb (PE10)) or PC6 (SP-A mAb (PC6)), which was followed by incubation with HRP-labeled anti-rabbit IgG or anti-mouse IgG (upper panel). As a negative control, the membranes in the absence of incubation with SP-A were also incubated with an anti-human SP-A polyclonal antibody (WB: SP-A pAb) or monoclonal antibodies PE10 (WB: SP-A mAb (PE10)) or PC6 (WB: SP-A mAb (PC6)), which was followed by incubation with HRP-labeled anti-rabbit IgG or anti-mouse IgG (lower panel). The data are representative of three independent experiments. B and C, experimental paradigm described in A was performed in H441 cells (B) and CHOK1 cells stably expressing EGFR (C) by using an anti-human SP-A polyclonal antibody, which was followed by incubation with HRP-labeled anti-rabbit IgG. The data are representative of three independent experiments.
Mrc 5 Human Embryonal Lung Fibroblast Cell Line, supplied by LGC Promochem, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/mrc-5 human embryonal lung fibroblast cell line/product/LGC Promochem
Average 90 stars, based on 1 article reviews
mrc-5 human embryonal lung fibroblast cell line - by Bioz Stars, 2026-03
90/100 stars
  Buy from Supplier

90
Shanghai iCELL Biotechnology Co Ltd human normal lung epithelial cell-line beas-2b
SP-A binds to EGFR in A549 cells, <t>H441</t> cells, and CHOK1 cells stably expressing EGFR. A, whole-cell lysate of A549 cells was immunoprecipitated (IP) with anti-EGFR monoclonal antibody Ab-11 or control IgG (0. 8 μg) at 4 °C for 16 h. The samples and BSA (200 ng/lane) were subjected to SDS-PAGE and transferred onto PVDF membranes. The membranes were incubated with or without SP-A (1 μg/ml) for 16 h. The membranes not incubated with SP-A were subjected to Western blotting using an anti-human EGFR monoclonal antibody (WB: EGFR). The membranes incubated with SP-A were then treated with an anti-human SP-A polyclonal antibody (SP-A pAb) or monoclonal antibodies PE10 (SP-A mAb (PE10)) or PC6 (SP-A mAb (PC6)), which was followed by incubation with HRP-labeled anti-rabbit IgG or anti-mouse IgG (upper panel). As a negative control, the membranes in the absence of incubation with SP-A were also incubated with an anti-human SP-A polyclonal antibody (WB: SP-A pAb) or monoclonal antibodies PE10 (WB: SP-A mAb (PE10)) or PC6 (WB: SP-A mAb (PC6)), which was followed by incubation with HRP-labeled anti-rabbit IgG or anti-mouse IgG (lower panel). The data are representative of three independent experiments. B and C, experimental paradigm described in A was performed in H441 cells (B) and CHOK1 cells stably expressing EGFR (C) by using an anti-human SP-A polyclonal antibody, which was followed by incubation with HRP-labeled anti-rabbit IgG. The data are representative of three independent experiments.
Human Normal Lung Epithelial Cell Line Beas 2b, supplied by Shanghai iCELL Biotechnology Co Ltd, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/human normal lung epithelial cell-line beas-2b/product/Shanghai iCELL Biotechnology Co Ltd
Average 90 stars, based on 1 article reviews
human normal lung epithelial cell-line beas-2b - by Bioz Stars, 2026-03
90/100 stars
  Buy from Supplier

90
Yingrun Biotechnologies Inc human lung cancer cell line a549
SP-A binds to EGFR in A549 cells, <t>H441</t> cells, and CHOK1 cells stably expressing EGFR. A, whole-cell lysate of A549 cells was immunoprecipitated (IP) with anti-EGFR monoclonal antibody Ab-11 or control IgG (0. 8 μg) at 4 °C for 16 h. The samples and BSA (200 ng/lane) were subjected to SDS-PAGE and transferred onto PVDF membranes. The membranes were incubated with or without SP-A (1 μg/ml) for 16 h. The membranes not incubated with SP-A were subjected to Western blotting using an anti-human EGFR monoclonal antibody (WB: EGFR). The membranes incubated with SP-A were then treated with an anti-human SP-A polyclonal antibody (SP-A pAb) or monoclonal antibodies PE10 (SP-A mAb (PE10)) or PC6 (SP-A mAb (PC6)), which was followed by incubation with HRP-labeled anti-rabbit IgG or anti-mouse IgG (upper panel). As a negative control, the membranes in the absence of incubation with SP-A were also incubated with an anti-human SP-A polyclonal antibody (WB: SP-A pAb) or monoclonal antibodies PE10 (WB: SP-A mAb (PE10)) or PC6 (WB: SP-A mAb (PC6)), which was followed by incubation with HRP-labeled anti-rabbit IgG or anti-mouse IgG (lower panel). The data are representative of three independent experiments. B and C, experimental paradigm described in A was performed in H441 cells (B) and CHOK1 cells stably expressing EGFR (C) by using an anti-human SP-A polyclonal antibody, which was followed by incubation with HRP-labeled anti-rabbit IgG. The data are representative of three independent experiments.
Human Lung Cancer Cell Line A549, supplied by Yingrun Biotechnologies Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/human lung cancer cell line a549/product/Yingrun Biotechnologies Inc
Average 90 stars, based on 1 article reviews
human lung cancer cell line a549 - by Bioz Stars, 2026-03
90/100 stars
  Buy from Supplier

90
Qinhuangdao Lihua Starch Co Ltd a549 human lung adenocarcinoma epithelial cell line
Cyclin D1 expression in <t>A549</t> cells in groups A-E following treatment for 48 h. Lanes: A, nimotuzumab; B, cisplatin; C, nimotuzumab followed by cisplatin; D, nimotuzumab and cisplatin simultaneously; and E, untreated control.
A549 Human Lung Adenocarcinoma Epithelial Cell Line, supplied by Qinhuangdao Lihua Starch Co Ltd, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/a549 human lung adenocarcinoma epithelial cell line/product/Qinhuangdao Lihua Starch Co Ltd
Average 90 stars, based on 1 article reviews
a549 human lung adenocarcinoma epithelial cell line - by Bioz Stars, 2026-03
90/100 stars
  Buy from Supplier

90
Takeda human esophageal carcinoma cells
Cyclin D1 expression in <t>A549</t> cells in groups A-E following treatment for 48 h. Lanes: A, nimotuzumab; B, cisplatin; C, nimotuzumab followed by cisplatin; D, nimotuzumab and cisplatin simultaneously; and E, untreated control.
Human Esophageal Carcinoma Cells, supplied by Takeda, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/human esophageal carcinoma cells/product/Takeda
Average 90 stars, based on 1 article reviews
human esophageal carcinoma cells - by Bioz Stars, 2026-03
90/100 stars
  Buy from Supplier

90
China Center for Type Culture Collection human fetal lung fibroblasts mrc5
Cyclin D1 expression in <t>A549</t> cells in groups A-E following treatment for 48 h. Lanes: A, nimotuzumab; B, cisplatin; C, nimotuzumab followed by cisplatin; D, nimotuzumab and cisplatin simultaneously; and E, untreated control.
Human Fetal Lung Fibroblasts Mrc5, supplied by China Center for Type Culture Collection, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/human fetal lung fibroblasts mrc5/product/China Center for Type Culture Collection
Average 90 stars, based on 1 article reviews
human fetal lung fibroblasts mrc5 - by Bioz Stars, 2026-03
90/100 stars
  Buy from Supplier

90
Pasteur Institute human lung carcinoma qu-db cell line
Cyclin D1 expression in <t>A549</t> cells in groups A-E following treatment for 48 h. Lanes: A, nimotuzumab; B, cisplatin; C, nimotuzumab followed by cisplatin; D, nimotuzumab and cisplatin simultaneously; and E, untreated control.
Human Lung Carcinoma Qu Db Cell Line, supplied by Pasteur Institute, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/human lung carcinoma qu-db cell line/product/Pasteur Institute
Average 90 stars, based on 1 article reviews
human lung carcinoma qu-db cell line - by Bioz Stars, 2026-03
90/100 stars
  Buy from Supplier

90
JCRB Cell Bank rerf-lc-ms human lung adenocarcinoma cells
Cyclin D1 expression in <t>A549</t> cells in groups A-E following treatment for 48 h. Lanes: A, nimotuzumab; B, cisplatin; C, nimotuzumab followed by cisplatin; D, nimotuzumab and cisplatin simultaneously; and E, untreated control.
Rerf Lc Ms Human Lung Adenocarcinoma Cells, supplied by JCRB Cell Bank, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/rerf-lc-ms human lung adenocarcinoma cells/product/JCRB Cell Bank
Average 90 stars, based on 1 article reviews
rerf-lc-ms human lung adenocarcinoma cells - by Bioz Stars, 2026-03
90/100 stars
  Buy from Supplier

90
Biotechnology Information human lung endothelial cell line hlmvec
SFK-targeted inhibitors suppress direct radiation-induced myofibroblast activation. ( A ) Comparison gene expression of SRC, YES1 and fibrosis markers in <t>HLMVEC,</t> 24 h after 10 Gy direct irradiation. The NCBI public dataset, GSE179810, was used. ( B ) SFKs expression and activation by direct irradiation in BEAS-2B cells. ( C ) Myofibroblast activation by direct irradiation in MRC5 cells. ( D ) Myofibroblast activation and its mechanism following direct irradiation in BEAS-2B cells. Total protein levels are shown in . ( E, F ) Reversal of direct radiation-induced myofibroblast activation by SFK-inhibitors. Total protein levels are shown in . ( G ) Schematic illustration representing these results. All western blot analyses in this study were repeated three times independently.
Human Lung Endothelial Cell Line Hlmvec, supplied by Biotechnology Information, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/human lung endothelial cell line hlmvec/product/Biotechnology Information
Average 90 stars, based on 1 article reviews
human lung endothelial cell line hlmvec - by Bioz Stars, 2026-03
90/100 stars
  Buy from Supplier

Image Search Results


SP-A binds to EGFR in A549 cells, H441 cells, and CHOK1 cells stably expressing EGFR. A, whole-cell lysate of A549 cells was immunoprecipitated (IP) with anti-EGFR monoclonal antibody Ab-11 or control IgG (0. 8 μg) at 4 °C for 16 h. The samples and BSA (200 ng/lane) were subjected to SDS-PAGE and transferred onto PVDF membranes. The membranes were incubated with or without SP-A (1 μg/ml) for 16 h. The membranes not incubated with SP-A were subjected to Western blotting using an anti-human EGFR monoclonal antibody (WB: EGFR). The membranes incubated with SP-A were then treated with an anti-human SP-A polyclonal antibody (SP-A pAb) or monoclonal antibodies PE10 (SP-A mAb (PE10)) or PC6 (SP-A mAb (PC6)), which was followed by incubation with HRP-labeled anti-rabbit IgG or anti-mouse IgG (upper panel). As a negative control, the membranes in the absence of incubation with SP-A were also incubated with an anti-human SP-A polyclonal antibody (WB: SP-A pAb) or monoclonal antibodies PE10 (WB: SP-A mAb (PE10)) or PC6 (WB: SP-A mAb (PC6)), which was followed by incubation with HRP-labeled anti-rabbit IgG or anti-mouse IgG (lower panel). The data are representative of three independent experiments. B and C, experimental paradigm described in A was performed in H441 cells (B) and CHOK1 cells stably expressing EGFR (C) by using an anti-human SP-A polyclonal antibody, which was followed by incubation with HRP-labeled anti-rabbit IgG. The data are representative of three independent experiments.

Journal: The Journal of Biological Chemistry

Article Title: Surfactant protein A down-regulates epidermal growth factor receptor by mechanisms different from those of surfactant protein D

doi: 10.1074/jbc.M117.800771

Figure Lengend Snippet: SP-A binds to EGFR in A549 cells, H441 cells, and CHOK1 cells stably expressing EGFR. A, whole-cell lysate of A549 cells was immunoprecipitated (IP) with anti-EGFR monoclonal antibody Ab-11 or control IgG (0. 8 μg) at 4 °C for 16 h. The samples and BSA (200 ng/lane) were subjected to SDS-PAGE and transferred onto PVDF membranes. The membranes were incubated with or without SP-A (1 μg/ml) for 16 h. The membranes not incubated with SP-A were subjected to Western blotting using an anti-human EGFR monoclonal antibody (WB: EGFR). The membranes incubated with SP-A were then treated with an anti-human SP-A polyclonal antibody (SP-A pAb) or monoclonal antibodies PE10 (SP-A mAb (PE10)) or PC6 (SP-A mAb (PC6)), which was followed by incubation with HRP-labeled anti-rabbit IgG or anti-mouse IgG (upper panel). As a negative control, the membranes in the absence of incubation with SP-A were also incubated with an anti-human SP-A polyclonal antibody (WB: SP-A pAb) or monoclonal antibodies PE10 (WB: SP-A mAb (PE10)) or PC6 (WB: SP-A mAb (PC6)), which was followed by incubation with HRP-labeled anti-rabbit IgG or anti-mouse IgG (lower panel). The data are representative of three independent experiments. B and C, experimental paradigm described in A was performed in H441 cells (B) and CHOK1 cells stably expressing EGFR (C) by using an anti-human SP-A polyclonal antibody, which was followed by incubation with HRP-labeled anti-rabbit IgG. The data are representative of three independent experiments.

Article Snippet: The H441 human lung adenocarcinoma cell line was obtained from ATCC and maintained in RPMI 1640 medium (Sigma) with 10% (v/v) FCS.

Techniques: Stable Transfection, Expressing, Immunoprecipitation, Control, SDS Page, Incubation, Western Blot, Bioprocessing, Labeling, Negative Control

Cyclin D1 expression in A549 cells in groups A-E following treatment for 48 h. Lanes: A, nimotuzumab; B, cisplatin; C, nimotuzumab followed by cisplatin; D, nimotuzumab and cisplatin simultaneously; and E, untreated control.

Journal: Oncology Letters

Article Title: Antitumor activity of nimotuzumab in combination with cisplatin in lung cancer cell line A549 in vitro

doi: 10.3892/ol.2018.7923

Figure Lengend Snippet: Cyclin D1 expression in A549 cells in groups A-E following treatment for 48 h. Lanes: A, nimotuzumab; B, cisplatin; C, nimotuzumab followed by cisplatin; D, nimotuzumab and cisplatin simultaneously; and E, untreated control.

Article Snippet: Cell culture The A549 human lung adenocarcinoma epithelial cell line (supplied by the Central Laboratory of Qinhuangdao No. 1 People's Hospital) was cultured in Dulbecco's modified Eagle's medium (Gibco; Thermo Fisher Scientific, Inc., Waltham, MA, USA) containing 10% fetal bovine serum (FBS; Zhejiang Tianhang Biotechnology Co., Ltd., Huzhou, China), 1 U/ml penicillin and 1 mg/ml streptomycin at 37°C, with 5% CO 2 and 95% humidity.

Techniques: Expressing, Control

SFK-targeted inhibitors suppress direct radiation-induced myofibroblast activation. ( A ) Comparison gene expression of SRC, YES1 and fibrosis markers in HLMVEC, 24 h after 10 Gy direct irradiation. The NCBI public dataset, GSE179810, was used. ( B ) SFKs expression and activation by direct irradiation in BEAS-2B cells. ( C ) Myofibroblast activation by direct irradiation in MRC5 cells. ( D ) Myofibroblast activation and its mechanism following direct irradiation in BEAS-2B cells. Total protein levels are shown in . ( E, F ) Reversal of direct radiation-induced myofibroblast activation by SFK-inhibitors. Total protein levels are shown in . ( G ) Schematic illustration representing these results. All western blot analyses in this study were repeated three times independently.

Journal: Theranostics

Article Title: Prevention of radiotherapy-induced pro-tumorigenic microenvironment by SFK inhibitors

doi: 10.7150/thno.100970

Figure Lengend Snippet: SFK-targeted inhibitors suppress direct radiation-induced myofibroblast activation. ( A ) Comparison gene expression of SRC, YES1 and fibrosis markers in HLMVEC, 24 h after 10 Gy direct irradiation. The NCBI public dataset, GSE179810, was used. ( B ) SFKs expression and activation by direct irradiation in BEAS-2B cells. ( C ) Myofibroblast activation by direct irradiation in MRC5 cells. ( D ) Myofibroblast activation and its mechanism following direct irradiation in BEAS-2B cells. Total protein levels are shown in . ( E, F ) Reversal of direct radiation-induced myofibroblast activation by SFK-inhibitors. Total protein levels are shown in . ( G ) Schematic illustration representing these results. All western blot analyses in this study were repeated three times independently.

Article Snippet: To determine if myofibroblast activation is directly induced by irradiation, we examined the National Center for Biotechnology Information (NCBI) public datasets on the human lung endothelial cell line HLMVEC.

Techniques: Activation Assay, Comparison, Gene Expression, Irradiation, Expressing, Western Blot